Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera

Production of high-titer helper-free retroviruses by transient transfection.

Warren S. Pear, Garry P. Nolan, Martin Scott et al. · Proceedings of the National Academy of Sciences · 1993 · 2.3K citations · Full text

Viral Replication, Xenotransplantation, Synthetic Virology +13

Mechanism of cholera toxin action: Covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system

Dan Cassel, Thomas Pfeuffer · Proceedings of the National Academy of Sciences · 1978 · 911 citations · Full text

Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development

John J. Mekalanos, Gregory D. Pearson, Nigel Harford et al. · Nature · 1983 · 636 citations · Full text

Virulence Factor, Pathogenesis, Pathogen Characterization +4

SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR

MyronM. Levine, D A Herrington, Genevieve Losonsky et al. · The Lancet · 1988 · 323 citations

Vaccination, Cvd 103, Mucosal Vaccination +7

Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques

Myron M. Levine, James B. Kaper, D A Herrington et al. · Infection and Immunity · 1988 · 296 citations · Full text

Vibrio Cholerae O1, Immunology, Deletion Mutants +17